BCS Q1 2026 Earnings EPS Beat by 1036 Despite Slight Stock Decline NBHC Q1 2026 Earnings EPS Misses Estimates as Shares Edge Higher Dyne Therapeutics Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Focus Limoneira LMNR Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Stock Eases Aditxt Inc ADTX Q3 2025 Earnings Deepening Losses and No Revenue Weigh on Shares Autolus Therapeutics AUTL Gains 268 as Stock Nears Key Resistance Level Terrestrial Energy Inc IMSR Surges Over 8 on Renewed Investor Interest Alto Ingredients Inc ALTO Surges 335 Testing Key Resistance at 566 CAMP4 Therapeutics Surges 45 as Biotech Sentiment Improves CAMP Tests Key Resistance NXT Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally